TickerFacts.

Sigyn Therapeutics, Inc. (SIGY): Capital Expenditures

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2024-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$860
Year ended 2022-12-31
-1.8%
5-year compound annual growth
$29.3K2014-12-31: $3.5K2015-12-31: $2.5K2017-12-31: $9402018-12-31: $3.0K2021-12-31: $29.3K2022-12-31: $860$860
2014-12-31 Capital Expenditures (USD) 2022-12-31
Period endedCapital ExpendituresChange YoYSource filing
2022-12-31$860-97.1%2024-02-20, From 2022-01-01
2021-12-31$29.3Kn/a2023-03-31, From 2021-01-01
No annual figure between 2018-12-31 and 2021-12-31.
2018-12-31$3.0K+213.8%2020-03-30, From 2018-01-01
2017-12-31$940n/a2019-04-01, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31$2.5K-29.3%2016-03-30, From 2015-01-01
2014-12-31$3.5Kn/a2016-03-30, From 2014-01-01